- Aerospace & Defense
- Big science
- Work at ARQUIMEA
ARQUIMEA has reached a collaboration agreement with the pharmaceutical laboratory Areafar for the exclusive distribution of Siluete Healthy Balm, the first lip balm that helps to avoid snacking, in pharmacies throughout Spain.
Areafar, a leading company in the distribution of pharmaceutical products, will contribute its experience in the sector to introduce Siluete in the national pharmacy channel. Its commitment to products that meet the highest quality standards and contain natural ingredients that are as environmentally friendly as possible will continue with the addition of Siluete to its portfolio.
ARQUIMEA is the laboratory responsible for developing Siluete, a lip balm that helps avoid snacking between meals through sensory stimuli -taste, smell, touch- that have an impact on decision-making.
Siluete is formulated from 100% natural ingredients and scientifically selected. The ingredients responsible for its anti-snacking capacity are menthol and eucalyptus essential oil, which provide freshness, and Sichuan pepper, capsicum frutencens, and spilantes acmella add an itching and tingling sensation to the lips. The combination of both sensations acts on our ability to resist impulses, such as the urge to snack between meals.
It was developed by a team of doctors and nutritionists and its efficacy was tested in two clinical studies, in which 88% of the participants stated that the application of the balm helped them to avoid snacking between meals.
“Siluete is neither an appetite suppressant nor a substitute for a varied and balanced diet. It is a stimulant product for topical application, innocuous and dosable at will to support the conscious decision to eat better.”, explains Dr. Miguel Fernández Tapia-Ruano, Medical Director of ARQUIMEA, specialist in Preventive Medicine and Public Health.
This new agreement between Areafar and ARQUIMEA will allow the introduction of Siluete Healthy Balm to the pharmacy and para-pharmacy channel in Spain and a growth opportunity for both companies.